Key indicators: single-crystal X-ray study; T = 113 K; mean (C-C) = 0.002 Å; disorder in main residue; R factor = 0.039; wR factor = 0.103; data-to-parameter ratio = 16.8.
In the title compound, C 34 H 41 N 7 O 5 Á4H 2 O (systematic name: ethyl 3-{[2-({4-[(Z)-amino(hexyloxycarbonylimino)methyl]-anilino}methyl)-1-methylbenzimidazole-5-carbonyl]pyridin-2-ylamino}propanoate tetrahydrate), the benzene and pyridine rings form dihedral angles of 5.4 (1) and 43.8 (1) , respectively, with the benzimidazole mean plane. The terminal butyl group is disordered over two conformations in a 0.756 (10):0.244 (10) ratio. There is an intramolecular N-HÁ Á ÁO hydrogen bond present. In the crystal, the water molecules are involved in the formation of O-HÁ Á ÁO, O-HÁ Á ÁN and N-HÁ Á ÁO hydrogen bonds, which link the components into layers parallel to the ab plane.
Related literature
For background to the anticoagulant drug dabigatran etexilate, see: Nagarakanti & Ellis (2012); Van Ryn et al. (2010) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). C3 0.0168 (6) 0.0220 (7) 0.0213 (7) 0.0005 (6) −0.0012 (5) −0.0027 (6) C4 0.0151 (6) 0.0236 (7) 0.0258 (7) −0.0052 (6) −0.0032 (5) −0.0016 (6) C5 0.0206 (7) 0.0167 (7) 0.0195 (7) −0.0034 (5) −0.0042 (5) −0.0020 (5) C6 0.0179 (7) 0.0214 (7) 0.0248 (7) −0.0014 (6) 0.0004 (6) −0.0069 (6) C7 0.0170 (7) 0.0218 (7) 0.0261 (7) −0.0054 (6) −0.0026 (6) −0.0028 (6) C8 0.0204 (7) 0.0207 (7) 0.0207 (7) −0.0032 (6) 0.0005 (6) −0.0012 (6) C9 0.0268 (8) 0.0300 (8) 0.0240 (7) 0.0000 (6) −0.0027 (6) −0.0123 (6) C10 0.0250 (8) 0.0403 (9) 0.0347 (9) 0.0004 (7) 0.0018 (7) −0.0148 (7 Symmetry codes: (i) x−1, y, z; (ii) −x+1, −y+2, −z+2; (iii) −x+1, −y+1, −z+2.
